Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
You may also be interested in...
NOAA Seafood Inspections Program had planned 1 May end to export certifications for fish oil supplements before granting 90-day extension as it talks with FDA about administering the program.
National Advertising Division, in rare review of an Rx drug firm’s challenge of supplement ad claims, reported Innovix Pharma pulled health claims for OmegaVia brand supplements challenged by Amarin. Innovix prevailed in defending its labeling as accurate and its name as not false advertising.
International Trade Commission launches investigation of adalimumab manufacturing processes in response to AbbVie complaint of misappropriation of trade secrets. District court dismissed trade secret suit on grounds it lacked jurisdiction. Trial in infringement suit is set for August.